| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $487.9M | -4.4% |
| Cost of Revenue | $306.7M | -9.4% |
| Gross Profit | $181.1M | +5.4% |
| R&D Expense | $13.0M | +8.9% |
| SG&A Expense | $69.1M | -18.2% |
| Operating Income | -$92.2M | +18.9% |
| Pre-tax Income | -$98.0M | +19.1% |
| Income Tax | $63K | +687.5% |
| Net Income | -$97.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29.0M | +8.0% |
| Accounts Receivable | $33.1M | -12.6% |
| Inventory | $56.9M | -15.0% |
| Current Assets | $126.4M | -10.9% |
| Total Assets | $307.8M | -21.2% |
| Current Liabilities | $101.0M | -9.0% |
| Long-term Debt | $70.7M | +135.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$17.9M | +67.3% |
| Capital Expenditures | $7.2M | -49.7% |
| Investing Cash Flow | -$7.5M | +53.1% |
| Financing Cash Flow | $27.5M | -50.7% |
| Free Cash Flow | -$25.1M | +63.7% |
| +18.9% |
| EPS (Basic) | -$0.91 | +22.2% |
| EPS (Diluted) | -$0.91 | +22.2% |
| Total Liabilities |
| $287.6M |
| +4.6% |
| Stockholders' Equity | $20.2M | -82.5% |